Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Distinct DNA Methylation Patterns Associated with Myalgic Encephalomyelitis

  |  Issue: October 2018  |  

The authors conclude their paper by proposing the screening of larger cohorts of patients with ME/CFS to determine the external validity of the identified epigenetic changes. They add that, should the changes be confirmed, they may serve as a useful diagnostic marker in the clinical setting.

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Trivedi MS, Oltra E, Sarria L, et al. Identification of myalgic encephalomyelitis/chronic fatigue syndrome-associated DNA methylation patterns. PLoS One. 2018 Jul 23;13(7):e0201066. eCollection 2018.

Related Articles

    Chronic Fatigue Syndrome: Why Myalgic Encephalomyelitis Is the Preferred Term and More

    CHICAGO—Joseph Breen, PhD, program officer at the National Institutes of Health in Bethesda, Md., opened the chronic fatigue syndrome (CFS) session at the Federation of Clinical Immunology Societies (FOCIS) 2017 meeting by asking presenters to describe the current state of the science to the key immunology stakeholders gathered in the room. The hope was that…

    DNA Methylation Profiles May Shed Light on the Evolution of Arthritis in Patients

    A study found DNA methylation profiling may predict if a patient will progress from a diagnosis of undifferentiated arthritis to that of rheumatoid arthritis (RA). The findings also suggest a pre-established epigenetic signature exists in patients diagnosed with undifferentiated arthritis that evolves into RA.